Armin Hekele

2.9k total citations · 1 hit paper
23 papers, 1.9k citations indexed

About

Armin Hekele is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Armin Hekele has authored 23 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 10 papers in Immunology and 7 papers in Oncology. Recurrent topics in Armin Hekele's work include Immunotherapy and Immune Responses (7 papers), Proteoglycans and glycosaminoglycans research (7 papers) and Glycosylation and Glycoproteins Research (4 papers). Armin Hekele is often cited by papers focused on Immunotherapy and Immune Responses (7 papers), Proteoglycans and glycosaminoglycans research (7 papers) and Glycosylation and Glycoproteins Research (4 papers). Armin Hekele collaborates with scholars based in Germany, United States and Switzerland. Armin Hekele's co-authors include Raul Andino, Ronald P. van Rij, Patrick H. O’Farrell, Edan Foley, Maria‐Carla Saleh, Amethyst Gillis, Clayton W. Beard, Peter Dall, Andrew J. Geall and Jeffrey B. Ulmer and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Nature Communications.

In The Last Decade

Armin Hekele

23 papers receiving 1.8k citations

Hit Papers

Nonviral delivery of self-amplifying RNA vaccines 2012 2026 2016 2021 2012 100 200 300 400 500

Peers

Armin Hekele
Katherine S. Bowdish United States
Robert Jan Lebbink Netherlands
Alex N. Zelensky Netherlands
David G. Gonzalez United States
Andres G. Grandea United States
Leanne Cooper Australia
Vincent C. Luca United States
Katherine S. Bowdish United States
Armin Hekele
Citations per year, relative to Armin Hekele Armin Hekele (= 1×) peers Katherine S. Bowdish

Countries citing papers authored by Armin Hekele

Since Specialization
Citations

This map shows the geographic impact of Armin Hekele's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armin Hekele with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armin Hekele more than expected).

Fields of papers citing papers by Armin Hekele

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armin Hekele. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armin Hekele. The network helps show where Armin Hekele may publish in the future.

Co-authorship network of co-authors of Armin Hekele

This figure shows the co-authorship network connecting the top 25 collaborators of Armin Hekele. A scholar is included among the top collaborators of Armin Hekele based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armin Hekele. Armin Hekele is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garcia, Alvaro Baeza, Armin Hekele, Kevin D. Augustijn, et al.. (2018). Neutralization of the Plasmodium-encoded MIF ortholog confers protective immunity against malaria infection. Nature Communications. 9(1). 2714–2714. 76 indexed citations
2.
MacLeod, Daniel T., Aaron J. Martin, Armin Hekele, et al.. (2017). Integration of a CD19 CAR into the TCR Alpha Chain Locus Streamlines Production of Allogeneic Gene-Edited CAR T Cells. Molecular Therapy. 25(4). 949–961. 223 indexed citations
3.
Hekele, Armin, Willy Bogers, Herman Oostermeijer, et al.. (2012). Reinventing the nucleic acid vaccine with self-amplifying RNA. Retrovirology. 9(S2). 2 indexed citations
4.
Geall, Andrew J., Ayush Verma, Gillis R. Otten, et al.. (2012). Nonviral delivery of self-amplifying RNA vaccines. Proceedings of the National Academy of Sciences. 109(36). 14604–14609. 525 indexed citations breakdown →
5.
Suphaphiphat, Pirada, Michael Franti, Armin Hekele, et al.. (2010). Mutations at positions 186 and 194 in the HA gene of the 2009 H1N1 pandemic influenza virus improve replication in cell culture and eggs. Virology Journal. 7(1). 157–157. 21 indexed citations
6.
Webster, Dale R., Armin Hekele, Adam S. Lauring, et al.. (2009). An Enhanced Single Base Extension Technique for the Analysis of Complex Viral Populations. PLoS ONE. 4(10). e7453–e7453. 9 indexed citations
7.
Chiu, Charles Y., Dale R. Webster, Michelle Dimon, et al.. (2008). The Long March: A Sample Preparation Technique that Enhances Contig Length and Coverage by High-Throughput Short-Read Sequencing. PLoS ONE. 3(10). e3495–e3495. 25 indexed citations
8.
Saleh, Maria‐Carla, Ronald P. van Rij, Armin Hekele, et al.. (2006). The endocytic pathway mediates cell entry of dsRNA to induce RNAi silencing. Nature Cell Biology. 8(8). 793–802. 420 indexed citations
9.
Offner, Sonja, Armin Hekele, Ulrike Teichmann, et al.. (2004). Epithelial tight junction proteins as potential antibody targets for pancarcinoma therapy. Cancer Immunology Immunotherapy. 54(5). 431–445. 54 indexed citations
10.
Li‐Weber, Min, Oskar Laur, Armin Hekele, et al.. (1998). A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential for responsiveness to TCR-mediated activation. European Journal of Immunology. 28(8). 2373–2383. 52 indexed citations
11.
Perschl, Astrid, et al.. (1998). Blockade of metastasis formation by CD44-receptor globulin. International Journal of Cancer. 75(6). 919–924. 24 indexed citations
12.
Perschl, Astrid, et al.. (1998). Blockade of metastasis formation by CD44‐receptor globulin. International Journal of Cancer. 75(6). 919–924. 4 indexed citations
15.
Dall, Peter, Armin Hekele, Hans Ikenberg, et al.. (1996). Increasing incidence of CD44v7/8 epitope expression during uterine cervical carcinogenesis. International Journal of Cancer. 69(2). 79–85. 29 indexed citations
16.
Hekele, Armin, Peter Dall, Dirk Moritz, et al.. (1996). Growth retardation of tumors by adoptive transfer of cytotoxic T lymphocytes reprogrammed by CD44V6-specific SCFV: ζ-chimera. International Journal of Cancer. 68(2). 232–238. 46 indexed citations
17.
Sherman, Larry S., Jonathan P. Sleeman, Peter Dall, et al.. (1996). The CD44 Proteins in Embryonic Development and in Cancer. Current topics in microbiology and immunology. 213 ( Pt 1). 249–269. 52 indexed citations
18.
Wels, Winfried S., Roger R. Beerli, Mathias Schmidt, et al.. (1995). EGF receptor and p185erbB‐2‐specific single‐chain antibody toxins differ in their cell‐killing activity on tumor cells expressing both receptor proteins. International Journal of Cancer. 60(1). 137–144. 88 indexed citations
19.
Moll, Jürgen, Jonathan P. Sleeman, Keitaro Kondo, et al.. (1994). Analysis of molecular functions of the tumor metastasis promoting surface molecule CD44v4-v7 using transgenic mice.. PubMed. 24. 142–51. 9 indexed citations
20.
Hekele, Armin & Hildburg Beier. (1991). Nucleotide sequence and functional characterization of a mitochondrial tRNATrpfromTetrahymena thermophila. Nucleic Acids Research. 19(8). 1941–1941. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026